Published in BMC Cancer on June 18, 2014
Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma. Oncotarget (2016) 0.78
Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma. Oncotarget (2016) 0.75
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol (2001) 5.99
Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89
The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci U S A (1999) 2.87
The filamins: organizers of cell structure and function. Cell Adh Migr (2011) 2.50
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res (2006) 2.43
Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res (2006) 2.37
Retracted Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res (2010) 2.24
Identification of filamin as a novel ligand for caveolin-1: evidence for the organization of caveolin-1-associated membrane domains by the actin cytoskeleton. Mol Biol Cell (2000) 1.90
Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J Clin Oncol (2004) 1.87
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res (2002) 1.82
Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein. J Cell Biol (2000) 1.82
Structural basis for vertebrate filamin dimerization. Structure (2005) 1.67
The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin. Nat Cell Biol (2000) 1.61
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52
Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol (1999) 1.33
Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction. J Biol Chem (1998) 1.28
Glioma therapy in adults. Neurologist (2006) 1.26
Molecular cloning of human ABPL, an actin-binding protein homologue. Biochem Biophys Res Commun (1998) 1.26
Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res (2009) 1.20
Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res (2004) 1.17
Regulation of glioma cell migration by serine-phosphorylated P311. Neoplasia (2005) 1.11
Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Cancer Res (2005) 1.10
Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc Natl Acad Sci U S A (1999) 1.07
The cytoskeleton protein filamin-A is required for an efficient recombinational DNA double strand break repair. Cancer Res (2009) 1.07
Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival. Int J Cancer (2005) 1.06
Identification of a human glioma antigen, SOX6, recognized by patients' sera. Oncogene (2004) 1.05
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma. Cancer Sci (2009) 1.02
Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer (2002) 1.02
Complex roles of filamin-A mediated cytoskeleton network in cancer progression. Cell Biosci (2013) 0.95
Filamin-A as a marker and target for DNA damage based cancer therapy. DNA Repair (Amst) (2011) 0.91
The actin cross-linker Filamin/Cheerio mediates tumor malignancy downstream of JNK signaling. J Cell Sci (2012) 0.90
An alliance between Ras GTPase-activating protein, filamin C, and Ras GTPase-activating protein SH3 domain-binding protein regulates myocyte growth. J Biol Chem (2005) 0.85
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas. J Exp Clin Cancer Res (2012) 0.84
High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas. Anticancer Res (2008) 0.84
Inhibition of filamin-A reduces cancer metastatic potential. Int J Biol Sci (2012) 0.82
Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A (2011) 2.13
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab (2013) 1.86
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med (2012) 1.21
CD44 signaling through focal adhesion kinase and its anti-apoptotic effect. FEBS Lett (2002) 1.20
Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients. Cancer (2003) 1.19
Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res (2004) 1.17
BMP inhibition enhances axonal growth and functional recovery after spinal cord injury. J Neurochem (2008) 1.15
Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer (2004) 1.15
Cathepsin D is a potential serum marker for poor prognosis in glioma patients. Cancer Res (2005) 1.10
Gene expression profiling reveals the mechanism and pathophysiology of mouse liver regeneration. J Biol Chem (2003) 1.05
Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep (2006) 1.05
Pituitary cysts in childhood evaluated by MR imaging. AJNR Am J Neuroradiol (2005) 1.03
Gamma knife surgery for 1-10 brain metastases without prophylactic whole-brain radiation therapy: analysis of cases meeting the Japanese prospective multi-institute study (JLGK0901) inclusion criteria. J Neurooncol (2010) 1.03
Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma. Int J Oncol (2007) 1.03
A rare case of metastatic renal cell carcinoma resembling a nerve sheath tumor of the cauda equina. J Clin Neurosci (2004) 1.03
PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. Proc Natl Acad Sci U S A (2013) 1.00
Transient expansion of vestibular schwannoma following stereotactic radiosurgery. J Neurosurg (2008) 1.00
Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke. Stroke (2005) 0.99
Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism. J Exp Med (2002) 0.98
Hypervascular vestibular schwannomas. Surg Neurol (2002) 0.98
Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. J Neurosurg (2011) 0.98
Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine. Cell Tissue Res (2008) 0.97
Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors. Int J Radiat Oncol Biol Phys (2009) 0.96
Nationwide investigation of the current status of therapeutic neuroendoscopy for ventricular and paraventricular tumors in Japan. J Neurosurg (2011) 0.93
Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. Oncogene (2002) 0.92
The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Clin Cancer Res (2013) 0.91
Time of day and nutrients in feeding govern daily expression rhythms of the gene for sterol regulatory element-binding protein (SREBP)-1 in the mouse liver. J Biol Chem (2010) 0.91
S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer. Oncol Rep (2004) 0.91
A haplotype spanning two genes, ELN and LIMK1, decreases their transcripts and confers susceptibility to intracranial aneurysms. Hum Mol Genet (2006) 0.91
Acrolein, IL-6 and CRP as markers of silent brain infarction. Atherosclerosis (2008) 0.90
c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy. Front Biosci (Landmark Ed) (2009) 0.90
Gamma knife radiosurgery for metastatic brain tumors from lung cancer: a comparison between small cell and non-small cell carcinoma. J Neurosurg (2002) 0.89
Anaplastic oligodendroglial tumors harboring 1p/19q deletion can be successfully treated without radiotherapy. Anticancer Res (2011) 0.89
Gamma Knife surgery as sole treatment for multiple brain metastases: 2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg (2010) 0.89
Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma: a multiinstitutional, retrospective review of 180 patients. Cancer (2005) 0.89
Gamma Knife surgery for metastatic brain tumors without prophylactic whole-brain radiotherapy: results in 1000 consecutive cases. J Neurosurg (2006) 0.89
Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms. Hum Genet (2007) 0.88
Operation of a P300-based brain-computer interface by individuals with cervical spinal cord injury. Clin Neurophysiol (2010) 0.88
The vidian canal: radiological features in Japanese population and clinical implications. Neurol Med Chir (Tokyo) (2014) 0.88
Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci (2006) 0.87
Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis (2010) 0.87
Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells. Cancer Sci (2011) 0.86
Identification of Makorin 1 as a novel SEREX antigen of esophageal squamous cell carcinoma. BMC Cancer (2009) 0.85
Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas. J Exp Clin Cancer Res (2012) 0.84
Testing different brain metastasis grading systems in stereotactic radiosurgery: Radiation Therapy Oncology Group's RPA, SIR, BSBM, GPA, and modified RPA. J Neurosurg (2012) 0.84
High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas. Anticancer Res (2008) 0.84
Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma. Int J Oncol (2006) 0.84
Activation of Ras signaling pathways by pyrroloquinoline quinone in NIH3T3 mouse fibroblasts. Int J Mol Med (2007) 0.84
Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol (2005) 0.84
Craniofacial Resection for Sinonasal Malignant Tumors: Statistical Analysis of Surgical Outcome over 17 Years at a Single Institution. Skull Base (2011) 0.84
Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma. Cancer (2004) 0.84
Slit ventricle syndrome after cyst-peritoneal shunting for temporal arachnoid cyst in children--a clinical entity difficult to detect on neuroimaging study. Brain Dev (2002) 0.84
Regulation of transformed state by calpastatin via PKCepsilon in NIH3T3 mouse fibroblasts. Biochem Biophys Res Commun (2002) 0.84
Continuous intraoperative monitoring of abnormal muscle response in microvascular decompression for hemifacial spasm; a real-time navigator for complete relief. Neurosurg Rev (2013) 0.83
Endoscopic endonasal skull base reconstruction using a nasal septal flap: surgical results and comparison with previous reconstructions. Neurosurg Rev (2010) 0.83
Ovarian hyperstimulation caused by gonadotroph cell adenoma: a case report and review of the literature. Gynecol Endocrinol (2006) 0.83
Gamma Knife surgery for metastatic brain tumors. J Neurosurg (2008) 0.83
Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. J Neurosurg (2005) 0.83
Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain (2012) 0.83
Morphological changes on MR imaging of the normal pituitary gland related to age and sex: main emphasis on pubescent females. J Clin Neurosci (2002) 0.83
Endoscopic endonasal trans-sphenoidal optic nerve decompression for traumatic optic neuropathy--technical note. Neurol Med Chir (Tokyo) (2010) 0.83
BMP inhibits neurite growth by a mechanism dependent on LIM-kinase. Biochem Biophys Res Commun (2007) 0.83
Tumor shrinkage of vestibular schwannomas after Gamma Knife surgery: results after more than 5 years of follow-up. J Neurosurg (2010) 0.82
Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection. Am J Gastroenterol (2006) 0.82
Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β gene. Mol Ther (2010) 0.82
Gene expression profiles in liver regeneration with oval cell induction. Biochem Biophys Res Commun (2004) 0.81
In-house cDNA microarray analysis of gene expression profiles involved in SCC cell lines. Int J Mol Med (2003) 0.81
Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma. Acta Neurochir (Wien) (2009) 0.81
An mRNA amplification procedure with directional cDNA cloning and strand-specific cRNA synthesis for comprehensive gene expression analysis. Genomics (2004) 0.81
Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature. J Neurooncol (2014) 0.81
Expression of the WT1 gene -KTS domain isoforms suppresses the invasive ability of human lung squamous cell carcinoma cells. Int J Oncol (2008) 0.80
Stat6-protease but not Stat5-protease is inhibited by an elastase inhibitor ONO-5046. Biochem Biophys Res Commun (2003) 0.80
Activation of NFAT signal by p53-K120R mutant. FEBS Lett (2009) 0.80
Congenital spondylolysis of the axis with associated myelopathy. Case report. J Neurosurg (2003) 0.80
Detection of anti-CUEC-23 antibodies in serum of patients with esophageal squamous cell carcinoma: a possible new serum marker for esophageal cancer. J Gastroenterol (2009) 0.80